Modifiable lifestyle risk factors and survival after diagnosis with multiple myeloma

Author:

Cheah Simon12ORCID,Bassett Julie K.1,Bruinsma Fiona J.12,Hopper John2,Jayasekara Harindra12,Joshua Doug3,MacInnis Robert J.12,Prince H. Miles45,Southey Melissa C.167,Vajdic Claire M.8,van Leeuwen Marina T.9,Wong Doo Nicole10,Harrison Simon J.411ORCID,English Dallas R.12,Giles Graham G.126,Milne Roger L.126

Affiliation:

1. Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia

2. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

3. Royal Prince Alfred Hospital, Sydney Medical School, University of Sydney, Sydney, Australia

4. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

5. Epworth Healthcare, Melbourne, Australia

6. Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Melbourne, Australia

7. Department of Clinical Pathology, The University of Melbourne, Parkville, Australia

8. Kirby Institute, UNSW Sydney, Sydney, Australia

9. Centre for Big Data Research in Health, The University of New South Wales, Sydney, Australia

10. Concord Clinical School, University of Sydney, Sydney, Australia

11. Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Parkville, Australia

Funder

National Health and Medical Research Council

Australian Government

Cancer Council Victoria

Publisher

Informa UK Limited

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3